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Abstract
Background: With the development of high-throughput screening, a variety of genetic alterations has been found in
hepatocellular carcinoma (HCC). Although previous studies on HCC methylation profiles have focused on liver tissue, studies
using isolated hepatocytes are rare. The heterogeneity of liver composition may impact the genuine methylation status of
HCC; therefore, it is important to clarify the methylation profile of hepatocytes to aid in understanding the process of
tumorigenesis.
Methods and Findings: The global methylation profile of single hepatocytes isolated from liver tissue of hepatitis B virus
(HBV) related HCC (HBHC) was analyzed using Illumina Infinium Human Methylation27 BeadChips, and combined bisulfite
restriction analysis (COBRA) and bisulfite sequencing were used to validate the 20 significant hypermethylated genes
identified. In this study, we found many noteworthy differences in the genome-wide methylation profiles of single
hepatocytes of HBHC. Unsupervised hierarchical clustering analysis showed that hepatocyte methylation profiles could be
classified according to three cell types: hepatocytes of HCC, adjacent hepatocytes and normal hepatocytes. Among the 20
most hypermethylated genes in the hepatocytes of HBHC, 7 novel genes (WNK2, EMILIN2, TLX3, TM6SF1, TRIM58,
HIST1H4Fand GRASP) were found to be hypermethylated in HBHC and hypomethylated in paired adjacent liver tissues;
these findings have not been reported in previous studies on tissue samples.
Conclusion: The genome-wide methylation profile of purified single hepatocytes of HBHC was aided in understanding the
process of tumorigenesis, and a series of novel methylated genes found in this study have the potential to be biomarkers
for the diagnosis and prognosis of HBHC.
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Introduction
Hepatocellular carcinoma (HCC) is one of the most common
cancers in the world and is commonly developed from liver
cirrhosis that are secondary to viral infection [1]. China is one of
the highest prevalent areas of HCC as chronic hepatitis B carriers
account for more than 10% of its population. The prognosis of
HCC patients is poor even after partial hepatectomy due to the
high rates of metastasis and relapse [2,3], and there is an urgent
need to elucidate the mechanism of hepatocarcinogenesis.
Epigenetic changes have been reported recently as one of the
mechanisms of tumorigenesis, and DNA methylation, which is one
of the major epigenetic alterations, has also been reported in
HCC. Aberrant DNA methylation of promoter CpG islands has
been associated with global hypomethylation and specific loci
hypermethylation, which are believed to have potential as
diagnostic markers in the progression of malignant tumors. In
HCC, DNA hypermethylation of candidate genes, including
GSTP1 [4], RASSF1A [5], RIZ1, APC [6], SOCS1 [7], APC [8],
and E-cadherin[9], has been examined using methylation sensitive
polymerase chain reaction, combined bisulfite restriction analysis
(COBRA), and bisulfite sequencing techniques in previous studies.
With the development of genome-wide screening, the global
methylation profiling of cancer has become clearer than ever
before. A group of potential tumor biomarker genes has been
reported in HCC [10]. Different gene methylation profiles have
been found in HCCs with different etiological backgrounds
[11,12,13], pathophysiological processes [10], and histological
characteristics.
However, most of the large-scale screening profiles have been
performed on tissue samples. Tissues often consist of a heteroge-
neous population of cells. The same is also true in cancerous
tissues. In addition to tumor cells, HCC tissues can have
fibroblasts, stromal cells, vasculature, inflammatory cells and other
non-parenchymal cells [14]. Although these non-parenchymal
cells have some effect on the progression of cancer, this mixed
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status of cancer cells, making diagnosis difficult to determine and
experimental results hard to interpret.
Several studies from independent labs have reported gene
expression and proteomic profile changes in isolated cells
compared to primary tissues. Harrell et al. compared the gene
expression of whole organs to isolated cells from the organ and
showed a distinctly different gene expression profile, with only
minor overlap between the two samples [15]. Waanders et al.
reported that the proteomic analysis of single pancreatic islets was
different from that of pancreatic tissue, suggesting that single-cell
analysis is more readily accessible to proteomic measurements
[16]. Even the tumor epithelium and tumor-associated stroma
have shown different methylation profiles, as GSTP1 and
RARbeta2 were found to be hypermethylated in the tumor
epithelium and less so in tumor-associated stroma [17]. In the
context of the liver, hepatocytes from HCC have shown reduced
heterogeneity and contamination in tissue samples and present less
protein spots than HCC tissue [18]. Considering the difference
between isolated hepatocytes and liver tissue, the gene expression
and proteomic profiles of hepatocytes isolated from cirrhotic
nodules [19], fetal livers [20], HCC lymphatic metastases [21] and
neoplasms [18] have been studied. The analysis of these
hepatocytes has revealed not only specific patterns that may
reflect the prognosis and drug sensitivity of cancer cell [22,23] but
also the identity of genes involved in malignant transformation,
progression [24], and tumor metastasis [21]. The homogeneity of
isolated hepatocytes may allow the elucidation of the mechanism
of tumorigenesis in HCC, with the global genome-wide methyl-
ation profile of HCC cells being of particular interest.
In the present study, we used a four-step collagenase perfusion
method to separate hepatocytes from liver tissues and analyzed the
aberrant promoter methylation of three paired liver cancer
samples and adjacent liver samples using Illumina Infinium
Human Methylation27 BeadChips that contained 27,000 CpGs.
And to eliminate the effect of different clinical backgrounds, we
focused on HBV related HCC (HBHC). The CpG island
methylation profile of hepatocytes isolated from primary tissues
and distinct pathways in single hepatocytes from HBHC were
obtained and revealed a group of potential novel biomarkers in
HBHC.
Results
Isolation and characterization of separated cells from
liver tissues
For clarification, in this study, the hepatocytes separated from
live cancer tissues were called HHCs, while HAs were those that
were collected from adjacent non-cancerous liver tissues and HNs
were those that were isolated from normal liver tissues. The
isolated hepatocyte motility rate was similar in the three groups
(95%64%) using a four-step collagenase perfusion method;
therefore, a cell motility rate .90% was chosen for further
analysis. The total number of separated hepatocytes was
1.3860.386106 per gram of hepatic tissue, and the contamination
rate of non-parenchymal cells in the HHC population was ,2%,
with a small cellular fraction as determined using microscopic
analysis.
Genome-wide DNA methylation profiling identifies
methylated genes in freshly isolated hepatocytes and
liver tissues
Global DNA methylation profiles were measured using Illumina
Infinium Human Methylation27 BeadChips, which target 14,475
total refseq genes, 12,833 well-annotated genes described in the
NCBI CCDS database, 144 methylation hotspots in cancer genes,
982 cancer-related targets and 110 miRNA promoters. Three
pairs of HHCs and HAs were included for comparison using the
HNs as the control. Using this approach, the average methylation
rate of HHCs was higher than that of matched HAs (Figure 1) as
reported in previous study[25].
To distinguish the genes that were differentially methylated in
HHCs, methylated genes were filtered according to P,0.05 and a
delta b.0.15. HHCs showed 792 genes that were hypermethy-
lated and 533 genes that were hypomethylated compared with
HNs, and 345 and 796 genes were hypermethylated and
hypomethylated, when compared with HAs respectively. When
compared to both HAs and HNs combined, HHCs showed 315
and 460 genes that were hypermethylated and hypomethylated,
respectively. KEGG (Kyoto Encyclopedia of Genes and Genomes)
analyses were performed to identify the pathways with which the
aberrant genes in HHCs were associated. Hypermethylated genes
in HHCs were enriched in the KEGG pathway, most of which
have been reported to be involved in the following cancer
pathways: gap junction (p=9.1610-5), calcium signaling
(p=5.8610-4), natural killer cell-mediated cytotoxicity (p=3.66
10-3), cell adhesion molecules (p=4.3610-3), and apoptosis
(p=0.0322). Hypomethylated genes were enriched in cell
communication (p=5.3610-10) and calcium signaling (p=1.026
10-3; Tables 1, 2 and Figure 2) pathways.
We further restricted inclusion criteria as P,0.001 and the delta
b.0.15, which resulted in the identification of 63 CpG sites
corresponding to 62 genes (Table S1); the average distance from
the 63 CpG sites to the transcription start site (TSS) was
256.58 bp. A total of 50 CpG sites showed significantly higher
methylation in HHCs relative to the other two groups of
hepatocytes. While 10 CpG sites outside of the CpG islands
Figure 1. Average promoter methylation of single hepatocyte
samples measured by BeadChip. Average promoter methylation of
hepatocyte of normal liver (HN), adjacent liver (HA) and HCC (HHC) for
all the 27,000 CpG loci. The illustrative box plots represent the mean,
25th percentile, 75th percentile and range of the data. Significant
differences (P,0.05) between tumor and surrounding tissue are
represented with an asterisk (*).
doi:10.1371/journal.pone.0019862.g001
Methylation of Single Hepaocytes from Liver Cancer
PLoS ONE | www.plosone.org 2 May 2011 | Volume 6 | Issue 5 | e19862showed less methylation in HHCs, there were only 2 CpG sites
inside CpG islands that showed hypomethylation. A total of 45
CpG sites exhibited a significant monotonic decreasing trend in
the methylation rate (HHCs.HAs.HNs), while 8 CpG sites
showed increasing trends (HHCs,HAs,HNs). Among the 63
genes showing the most significant differences in methylation, 38
genes have been associated with cancer in previous studies. Among
them, 10 genes have been reported in HCC, and ZMYND10 [26],
SYK [27], DAB2IP [28], and DLEC1 [29] have been reported to
be tumor-suppressor genes in HCC. Unsupervised hierarchical
clustering analysis with a P,0.001 showed that in the single
hepatocytes group, the cells could be classified into three types:
HN, HA, HHC (Figure 3).
The methylation profile in HAs was also compared with that of
HNs, and 124 and 115 genes were identified as differently
methylated (p,0.05) and hypermethylated, respectively. A
number of these genes were associated with MAPK (FGF2,
BDNF, TGFB3, FGF23, and FGF17) and colorectal cancer (dcc,
cycs, and tgfb3) signaling pathway.
Methylation analysis in paired normal and liver cancer
tissues
To further investigate whether the methylation profiles of
isolated hepatocytes were consistent with tissue samples, we chose
the 20 most significantly hypermethylated genes in five pairs of
HBHC tissues and adjacent liver tissues for further validation
using COBRA. Two previously reported genes (ZMYND10 and
SYK) and one unknown gene (DKFZp434I1020) were excluded
f r o mt h ea n a l y s i s .T h eP C Rp r o d u c t so ft h e s es e v e n t e e ng e n e s
amplified from bisulfite-treated cancer and adjacent tissues were
digested using the methylation-sensitive restriction enzyme
BstUI. Two of the genes (KIF17 and ATP8A2) showed no
methylation in either cancer or matched tissues, and eight genes
(EPHA4, OVOL1, UTF1, ADAM8, BOLL, FOXE3, GU-
CY1A2, and ADCY5) were equally methylated in the two
groups. These ten genes were removed from further analysis,
and the remaining seven genes were analyzed in ten paired liver
tissues. These genes were frequently methylated in HBHC,
while those in the matched non-cancerous liver tissues were
Table 1. Hypermethylated gene in single hepatocytes from HBHC enriched in KEGG pathway.
KEGG Pathway Gene Number Gene Symbol Enrichment P Value
Neuroactive ligand-
receptor interaction
15 GRP83, CRHR2, ADRA2B, DAB2IP, ADRB3, DRD4,
EDNRB, F2R, GALR1, NPBWR1, HTR7, NMBR, NPY,
VIPR2, ALDH1A2
O=15;E=2.4491;R=6.1247;P=3.13e-8 3.13E-08
Gap junction 6 ADCY5, DAB2IP, ADCY4, CUCY1A2, CX36, TUBB6 O=6;E=0.7253;R=8.2724;P=9.10e-5 9.10E-05
Calcium signaling
pathway
7 DAB2IP, ADRB3, EDNRB, ADCY4, ERBB4, F2R, HTR7 O=7;E=1.4165;R=4.9418;P=5.85e-4 5.85E-04
Neurodegenerative
Disorders
3 NFH, NGFR, UCHL1 O=3;E=0.2901;R=10.3413;P=3.03e-3 3.03E-03
Natural killer cell
mediated cytotoxicity
5 VAV3, HLA-G, PIK3CD, SYK, TNFRS10F O=5;E=1.0155;R=4.9237;P=3.62e-3 3.62E-03
Cell adhesion
molecules (CAMs)
5 CNTNAP2, HLA-G, ITGA9, ITGB8, CD8A O=5;E=1.0581;R=4.7255;P=4.31e-3 4.31E-03
Insulin signaling pathway 5 MKNK2, PFKP, PIK3CD, PRKAR1B, IRS4 O=5;E=1.1093;R=4.5073;P=5.26e-3 5.26E-03
Amyotrophic lateral
sclerosis (ALS)
2 NEF3, NEFHG O=2;E=0.1451;R=13.7836;P=9.07e-3 9.07E-03
O is the observed gene number in the pathway. E is the expected gene number in the pathway (Expected number of genes in a specific pathway for an interesting gene
set = Total number of genes in the pathway for the reference set 6Total number of genes in the interesting set/Total number of genes in the reference set). R is the
ration of enrichment for the pathway (R=O/E). P is the p value indicating the significance of enrichment calculated from hypergeometric test. It is given for the
pathways with R.1.
doi:10.1371/journal.pone.0019862.t001
Table 2. Hypomethylated gene in single hepatoytes from HBHC enriched in KEGG pathway.
KEGG Pathway Gene Number Gene Symbol Enrichment P Value
Cell Communication 13 LAMC3, GJB4, CX40.1, K6IRS3, KRT1, KRT5, KRTHA1,
KRTHA3A, KRTHA3B, KRTHA4, KRTHA5, KRTHB4
O=13;E=1.2773;R=10.1777;P=5.35e-10 5.35E-10
Taste transduction 5 GNAS, GRM4, TRPM5, ACCN1, TAS2R8 O=5;E=0.5231;R=9.5584;P=1.71e-4 1.71E-04
Neuroactive ligand-
receptor interaction
11 CYSLTR1, GABRA6, GHRH, NPBWR2, GRIK5, GRM4,
GRM8, HRH2, MC3R, NTSR1, NMUR2
O=11;E=3.4912;R=3.1508;P=8.54e-4 8.54E-04
Calcium signaling
pathway
8 CYSLTR1, GNAL, GNAS, HRH2, NOS3, NTSR1, ATP2B3,
SLC8A1
O=8;E=2.0193;R=3.9618;P=1.02e-3 1.02E-03
Cytokine-cytokine
receptor interaction
9 IL17B, IL28B, XCR1, HGF, CCL7, CCL13, CCL18, TPO,
TNFRSF10A
O=9;E=2.9438;R=3.0573;P=3.02e-3 3.02E-03
Galactose metabolism 3 HK2, HK3, LALBA O=3;E=0.3649;R=8.2214;P=5.69e-3 5.69E-03
Streptomycin biosynthesis 2 HK2, HK3 O=2;E=0.1216;R=16.4474;P=6.23e-3 6.23E-03
doi:10.1371/journal.pone.0019862.t002
Methylation of Single Hepaocytes from Liver Cancer
PLoS ONE | www.plosone.org 3 May 2011 | Volume 6 | Issue 5 | e19862either methylated to a significantly lower extent or not
methylated at all. A summary of the promoter methylation
analysis is shown in Tables 3 and 4 and the cloning and
sequencing analysis results are shown in Figure 4. These results
indicate that cancer tissues have much higher methylation rates
than the related non-cancerous tissues, which confirm the results
from COBRA.
Expression analysis in cell lines with 5-aza-dc
To confirm the role of methylation in gene expression silencing,
we treated four hepatoma cell lines with the demethylating agent
5-aza-dc. Seven genes that were validated in ten paired HBHC
and adjacent liver tissues using COBRA were selected for this
experiment, and their expression was analyzed using real-time
quantitative polymerase chain reaction (RT-PCR). All of the
Figure 3. Heat map of methylated gene in the Illumina Infinium methylation assay. Heat map of 64 CpG locus were different methylated in
3 pairs of hepatocyte from HBHC(HHC) and adjacent liver(HA) with 2 normal liver(HN) as control(p,0.001). The hypermethylated and
hypomethylated genes were indicated by red and green respectively. Unsupervised hierarchical cluster analysis represents a significent
distinguishing HHCs from HAs and HNs. The Euclidean distance between two groups of samples is calculated by the average linkage measure
between members of the two groups concerned.
doi:10.1371/journal.pone.0019862.g003
Figure 2. Pathway analysis of single hepatocytes derived from HBHC. Significantly aberrant methylated gene (P,0.05) in HHC enriched in
KEGG pathway are summarized in A (hypermethylation) B (hypomethylation), NLRI, Neuroactive ligand-receptor interaction; ND, Neurodegenerative
Disorders; NKCMC, Natural killer cell mediated cytotoxicity; CAMs, Cell adhesion molecules;ALS, Amyotrophic lateral sclerosis; CC, Cell
Communication.
doi:10.1371/journal.pone.0019862.g002
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one cell line (Figure 5), and one gene, TLX3, was upregulated in
all four cell lines. The results are summarized in Table 5.
Discussion
Carcinogenesis is a multi-stage, multi-mechanistic process and
the details of the progression of a normal cell as it transforms into a
cancer that exhibits excessive proliferation and reduced apoptotic
potential are still unclear. The global methylation profile helps us
to clarify the progression of hepatocarcinogenesis. In this study, we
analyzed the methylation profiles of single hepatocyte isolated
from HBHC using Illumina Infinium Human Methylation27
BeadChips to better understand the molecular mechanisms
underlying tumorigenesis.
The collagenase perfusion method is a classic method to isolate
hepatocytes from liver tissues. This method were used to isolated
hepatocyte from normal liver[30,31], liver cirrhosis[32] and
HCC[20,22,23,33] to study molecular mechanisms. Fibrous liver
connective tissue was removed through successive perfusion with
EDTA, dispase, collagenase type IV, and DNase I. Centrifuged
at low speed to eliminate non-parenchymal cells. Single isolated
hepatocyte is not only different from liver tissue without the
latter’s heterogeneity which might influence the methylation
profile [13], but is also different from cell lines. Because cell lines
were cultured in vitro and did not have the background of
chronic viral infection, hypermethylation in cell lines could be a
background event caused by repeated passages and the culture
environment, which could be significantly different from primary
malignancies [34]. Therefore, we focused our study on freshly
isolated hepatocytes, which not only exhibit the pathology
background but are also homogeneous.
Using the isolated single hepatocytes from HBHC, we detected
novel genes that were specifically methylated. However, among
these genes, only a few overlapped with previous studies. Beside
the differences between single hepatocytes and liver tissue, one
explanation for these differences is that the studies varied in
pathogen, pathology, tumor grade, race and other clinical data. In
this study, we selected all samples according to the same criteria to
eliminate the effect of different clinical backgrounds. In addition,
all HCC specimens were moderately or poor differentiated, and all
patients suffered from hepatitis B virus (HBV) and exhibited the
same underlying cirrhosis etiology. Another explanation for the
variability of the findings from the multiple studies could be that
the methylation microarrays from each company detected
methylated genes in the human genome using different detection
methods with variations in the sensitivity of detection and filter
range.
In this study, the HHC methylation profile detected genes that
were linked with several cancer-associated pathways. Gap junction
genes (ADCY5, DAB2IP, ADCY4 CUCY1A2, CX36, and
TUBB6) were significantly hypermethylated in HHCs (p=
0.000091) and have shown significantly reduced expression in
HCC compared with normal livers in previous studies [35] [31].
Cancer was one of the first pathologies to be associated with gap
junction defects, and tumor formation, invasiveness and cancer
cell dissemination have all been closely correlated with gap
junctions[36]. The inhibition of gap junctional intercellular
communication (GJIC) results in a block in cell communication
and the loss of the control of endocrine regulation between normal
cells to regulate growth and terminally differentiate, thus resulting
in immortalization and escape from apoptosis [37,38]. GJIC is
postulated to be an important mechanism to control growth and
differentiation and eliminate the interference from non-parenchy-
mal liver cells, and it was significantly associated with isolated
hepatocyte methylation profiles.
Calcium signaling, cell adhesion molecules and apoptosis are all
closely related to gap junctions. Calcium signaling represents a
general mechanism of intercellular signaling via the gap junction-
mediated diffusion of Ca2+/inositol 1,4,5-triphosphate [37];
cancer cell transformation, cell proliferation and cell death are
associated with a major rearrangement of Ca2+ pumps, Na/Ca
exchangers and Ca2+ channels, which leads to enhanced
proliferation and an impaired ability to die that ultimately
determines cell fate [38]. Cell adhesion molecules play an
important role in regulating cell survival, proliferation and motility
Table 3. COBRA analysis of 17 selected genes in primary
tumor and adjacent liver.
Genes Primary Tumor Adjacent Liver P Value
WNK2 3/5 0/5 0.038
FOXE3 5/5 4/5 0.292
GUCY1A2 2/5 3/5 0.294
EMILIN2 3/5 0/5 0.038
TRIM58 3/5 0/5 0.038
ADCY5 4/5 2/5 0.197
OVAL1 3/5 2/5 0.527
ADAM8 5/5 4/5 0.292
GRASP 3/5 0/5 0.038
UTF1 4/5 4/5 1
BOLL 2/5 5/5 0.079
TM6SF1 4/5 0/5 0.01
KIF17 0/5 0/5 1
EPHA4 1/5 0/5 0.292
ATP8A2 3/5 3/5 1
HIST1H4F 3/5 0/5 0.038
TLX3 3/5 0/5 0.038
The genes selected from Illumina Infinium methylation assay were validated in
COBRA with five pairs primary tumor and adjacent liver, ten genes shared the
same methylation rate in primary and adjacent liver by our COBRA primers were
excluded.
doi:10.1371/journal.pone.0019862.t003
Table 4. COBRA analysis of 7 selected genes in primary tumor
and adjacent liver.
Genes Primary Tumor Adjacent Liver P Value
WNK2 7/10 2/10 0.025
EMILIN2 7/10 0/10 0.001
TRIM58 7/10 1/10 0.006
GRASP 7/10 2/10 0.025
TM6SF1 8/10 2/10 0.005
HIST1H4F 7/10 0/10 0.001
TLX3 6/10 1/10 0.02
Seven genes confirmed frequent hypermethylation in primary tumor tissues
(p,0.05) were selected for further analysis in ten pairs of primary tumor and
adjacent liver tissues, frequent hypermethylation (P,0.05) were observed in
these genes.
doi:10.1371/journal.pone.0019862.t004
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liver cancer. Inflammatory hepatitis might activate NF-kB by the
concerted action of cytokines that are resistant to apoptosis and
promote cell survival of pre-cancerous hepatocytes [27]. Another
pathway that is associated with cancer is natural killer cell-
mediated cytotoxicity. Nature killer cell(NK cell) play a role in
mediating innate host immune responses, which are regulated by a
balance between activating and inhibitory receptors. The
dysregulation of natural killer cell-mediated cytotoxicity breaks
this balance because upregulation of the ligands for inhibitory
receptors and/or the loss of ligands for activating receptors aids in
tumor cell escape from NK cell recognition [40].
Except the distinct pathways identified in HHCs, a group of
aberrantly methylated genes was selected. EPHA4, KIF17,
OVOL1, UTF1, ADAM8 BOLL, FOXE3, GUCY1A2, and
ADCY5 exhibited the same promoter methylation status in
Figure 4. DNA methylation status of seven selected genes in HBHC and adjacent liver tissue. COBRA analysis were performed as
amplified PCR of sodium bisulfite-converted genomic DNAs, PCR products incubated with BstUI to measure the methylation rate and samples
without incubation with BstUI were listed as control. Selected PCR products were cloned into T-A clones and sequencing. Five samples of each alleles
listed were shown by black and white circles represent methylated and unmethylated CpG dinucleotides respectively. "MI" was the abbreviation of
methylation index, calculated as the percentage of the methylated dinucleotides versus total. Detail methylated sites were marked in red, the
position of COBRA primers is also shown in blue, covering the region was respect to the transcription start site. AJ was the abbreviation of adjacent
liver tissue.
doi:10.1371/journal.pone.0019862.g004
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methylation is acquired during cirrhosis and chronic inflammation
with persistent viral infection during the pre-cancerous state before
the formation of the tumor. SYK and ZMYND10 (also known as
BLU) were hypermethylated in HHCs in our studies. These genes
have been reported to be methylated in HCC, indicative of tumor-
suppressor genes. SYK has been highly correlated with lower
overall survival rates. [26,27]. WNK2, emilin2, tlx3, tm6sf1,
trim58, hist1h4f, and grasp were significantly hypermethylated in
HBHC. Wnk2 belongs to a serine/threonine kinase subfamily that
has the catalytic lysine in a non-canonical position. WNK2 point
mutations have been found in lung cancer, adult glial tumors and
other solid tumor types, and it has also been reported to be a
tumor suppressor [41]. EMILIN2 belongs to a family of
extracellular matrix glycoproteins that contain an EMI domain
at the N-terminus and a C1q domain at the C-terminus.
EMILIN2 has been shown to suppress the growth of breast and
other cancer cells and trigger apoptosis in cancer cells via the
extrinsic apoptotic pathway following EMILIN2 binding to the
trail receptors DR4 and DR5 [42]. TLX3 has been shown to be
hypermethylated in prostate cancer [43]. Tm6sf1, trim58,
hist1h4f, and grasp were identified as novel hypermethylated
genes in HBHC; these genes were methylated in HHCs and
HBHC tissues, suggesting that the methylation of these genes
might have critical role in tumorigenesis and cancer progression.
These novel genes were upregulated in response to 5-aza-dc in at
least one of the tested cell lines, and based on the different invasive
behaviors of these cell lines, the low expression was regulated by
hypermethylation.
Another observation is the distinct methylation profile of
isolated hepatocytes from non-cancerous livers, which was
different from that of normal hepatocytes, as reported in previous
studies with tissue samples [6]; some pathways associated with
cancer were also found in adjacent cells. According to a recent
theory about tumorigenesis by Slaughter [44], field cancerization
results from the expansion of pre-neoplastic cells in early
tumorigenesis. Aberrantly methylated genes in adjacent cells
would affect the progress of hepatocarcinogenesis and would be
useful in early detection and risk assessment.
This study is the first report on the global methylation profiling
of hepatocytes isolated from tissues. Even with the small sample
size, the aberrant methylation profile of HHCs is distinct from that
of normal hepatocytes and reveals potential biomarkers in the
diagnosis and prognosis of HBHC. These novel methylated genes
should be further analyzed in larger clinical samples to elucidate
their clinical implication, and more samples with different
etiological backgrounds, pathophysiological processes, and histo-
logical characteristics should be used in further studies.
Materials and Methods
Patient specimens
All samples in this study were taken from a surgical specimen,
obtained through hepatectomy or liver transplantation. All the
patients have signed an informed-consent. No prisoners or organs
from prisoners were used in this study. All patients included in this
Figure 5. Gene re-expression after treated with 5-aza-dc. Gene expression level was analyzed by quantitative reverse transcription-
polymerase chain reaction. All selected genes were unregulated after treated with 10 uM 5-aza-dcC at least in one cell lines, the expression of cell
lines before 5-aza-dc treatment was analyzed as control.
doi:10.1371/journal.pone.0019862.g005
Table 5. Seven selected genes were analyzed in four cell lines
by RT-PCR.
Genes HepG2 7402 97L 97H
WNK2 151 0.68 1.38 0.086
EMILIN2 9.4 0.66 0.28 48.8
TLX3 6.8 1.3 6.8 8.02
TM6SF1 5.18 352.8 4.9 (-)
TRIM58 2.55 0.3 0.03 107.8
HIST1H4F 3.2 0.64 0.004 100.7
GRASP 5.66 0.65 0.05 (-)
The expression of the selected genes after treated with 5-aza-dc was
summarized in the table 5 and before treatment was used as control. The
relative expression rate = the expression of gene after treatment/the
expression of gene before treatment.
doi:10.1371/journal.pone.0019862.t005
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Zhejiang University in 2009. All experimental protocols and study
methods were approved by the Ethics Committee of the First
Affiliated Hospital, School of Medicine, Zhejiang University.
A total of 13 patients with HCC and 2 patients with hepatic
hemangioma were selected for analysis. All patients were male to
avoid sex-based variation, and the mean age was 46.84 years old
(5865.99). All HCC patients were hepatitis B virus (HBV) surface
antigen-positive without hepatitis C virus (HCV) infection and
exhibited the same underlying cirrhosis etiology. Clinical infor-
mation for these patients were summarized in Tables 6 and 7.
HBV surface antigen and anti-HCV antibody were measured
serologically. The collection of tumor tissues was strictly limited
inside the boundary of tumor, and adjacent non-cancerous liver
tissues was collected at least 3 cm from the tumor margins, all the
collections were under the supervision of a same pathologist. Each
sample was devided into two parts, one was used for methylation
profiling analysis, the other was histologically examined by two
experienced pathologists, confirming that under the microscope
there was no detectable normal liver cells inside the tumor samples
and no tumor cells in the surrounding liver tissues.
Three paired HBHC and adjacent liver tissues were perfused to
harvest single hepatocytes from tissues, and were then used for the
Illumina Infinium BeadChips analysis. Ten paired HBHC and
matching tissues were available for further validation. Two normal
adult liver tissues from the patients with hepatic hemangioma who
underwent partial hepatectomy without HBV or HCV infection
were used for comparison purposes. Tissue samples were freshly
frozen at 280uC or perfused immediately to harvest single cells.
Isolation of hepatocytes from liver tissues
Three paired tumors and adjacent liver tissues and normal livers
were isolated using a modified four-step collagenase perfusion
method as described previously [30,31]. The liver segments were
perfused by the extracorporeal circulating perfusion apparatus in a
sterile cell room. Four different buffer solutions supplemented,
respectively, with 0.37 mg/ml EDTA, 0.5% dispase, 0.05%
collagenase type IV (Gibco BRL, Grand Island, NY), and
40 ug/ml DNase I (Sigma, St. Louis, MO) were perfused
successively into small hepatic vessels for 40 minutes. Solid tumor
remnants were dispersed mechanically with a scalpel blade, and
then incubated in collagenase buffer for 20 min at 37uC. The
pooled suspensions were filtered by 100 um nylon mesh. Isolated
cells were harvested and centrifuged at 4uC at 50 g for 3 minutes,
and then the liver cells were resuspended in Dulbecco’s modified
Eagle’s medium (DMEM; Invitrogen, Carlsbad, CA) and
centrifuged twice at 4uC at 50 g for 1 min.
The hepatocytes were then stained using 0.4% trypan blue, and
cell motility and the number of isolated cells were calculated. DNA
was extracted from isolated hepatocytes and frozen liver tissues for
methylation analysis using the QIAamp DNA Mini Kit (Qiagen,
Valencia, Ca) according to the manufacturer’s instructions.
Illumina Infinium methylation assay
The Illumina Infinium 27k Human DNA methylation Bead-
Chip v1.2 was used to obtain genome-wide DNA methylation
profiles across approximately 27,000 CpGs, which were focused
on the promoter regions of 14,495 genes, in purified cell samples.
Bisulfite conversion of genomic DNA was performed using the
EZ DNA methylation Kit (Zymo Research, D5002, USA)
according to the protocol provided by the Illumina Infinium
Methylation Assay. Bisulfite-converted and -unconverted (i.e.,
methylated) sites were simultaneously evaluated using DNA
hybridization to site-specific probes attached to beads (one set
for unmethylated and the other for methylated sites), followed by
allele-specific base extension that included a fluorescent label. Two
different labels were used, and fluorescent signals were specific for
either the T (unmethylated) or C (methylated) alleles. Methylation
scores represented as b values were generated for each site using
Table 6. Clinicppathological features for 3 HBHC patients for
methylation profiling analysis.
Varible Case 1 Case 2 Case 3
Case number 631 560 564
Age (year) 58 41 53
Gender male male male
ALT 42 35 47
HBV-DNA 6.31610
4 2.01610
4 3.33610
5
Cirrhosis yes yes yes
Preoperative AFP
level (ng/ml)
12.1 2 .58344
Histopathologic
grading
moderate moderate poor
Tumor size (cm) 529
Tumor number single single multiple
PVTT 001
Childpagh BBC
doi:10.1371/journal.pone.0019862.t006
Table 7. Clinicppathological features for 10 HBHC patients
for validation analysis.
Variable No. of cases
No. of patients 10
Age(year) #50 7
.50 3
Gender Male 10
Female 0
Preoperative AFP level(ng/ml) #400 1
.400 9
Etiology HBV 10
HCV+other 0
Cirrhosis Yes 10
No 0
Tumor size(cm) #50 3
.50 7
Tumor number single 4
Multiple 6
Childpagh A4
B3
C3
Histopathologic grading well+moderate 4
poor 6
PVTT Yes 3
No 7
doi:10.1371/journal.pone.0019862.t007
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were computed based on the ratio of methylated to methylated
plus unmethylated signal outputs. Thus, the b values ranged from
0 (unmethylated) to 1 (fully methylated) on a continuous scale.
Initial array results were visualized using IlluminaHGenome Studio
software v1.0 (Illumina Inc., USA).
All computations and statistical analyses were performed using
the R package (R v2.10.1; http://www.r-project.org) and
Bioconductor [45]. Significant differences between the sample
groups were identified using the limma (Linear Models for
Microarray Analysis) package of the Bioconductor suite, and an
empirical Bayesian-moderated t-statistic hypothesis test between
the two specified phenotypic groups was performed [46] using
significance at P value ,0.05 with the absolute delta b value cutoff
set at 0.15.
Heat maps were created using Mev software [47]. The
Euclidean distance between two groups of samples was calculated
by the average linkage measure (the mean of all pair-wise distances
(linkages) between members of the two groups concerned). Gene
annotation and enrichment analyses were performed using KEGG
databases using the DAVID Bioinformatics Resources (2008;
http://david.abcc.ncifcrf.gov/) [48] interfaces and WebGestalt
(http://bioinfo.vanderbilt.edu/webgestalt/) [49], respectively.
Combined bisulfite restriction analysis (COBRA) and
bisulfite sequencing
Genomic DNA (1 mg) from freshly purified hepatocytes and
liver tissues was bisulfite-converted using EpiTect Bisulfite Kits
(Qiagen, Valencia, CA, USA) and used for PCR amplification.
PCR primers were designed using Methyl Primer Express to
amplify regions of CpG islands that overlapped or were close to
the transcription start sites. All primer sequences and the
mythylated sites are listed in Table 8. The PCR products were
then digested with the methylation-sensitive endonuclease BstUI at
60uC for 2 hours. Digested PCR fragments were visualized using a
2% agarose gel, and the PCR products for bisulfite sequencing
were cloned into the pGEM-T easy vector (Promage, USA)
following the manufacturer’s instructions. After being transfected
into Escherichia coli, up to 10 clones were selected and sequenced
Table 8. Primers used for COBRA and sequencing.
Primer sequence Position(TSS=+1)
Offical symbol Offical full name Location Forward Reverse Forward 59 Reverse 59 Length
WNK2 Wnk lysine deficient
protein kinase 2
9q22.3 TTTTGGTTTATAGAG
ATGGA
CTTACAAAACAAA
AACACCC
220 +240 255 bp
EMILIN2 Elastin microfibril
interfacer 2
18p11.3 TATTGGAAATGTTGT
AACGTAGATT
ACCGTCTAAACTA
CCACATCC
2250 +164 414 bp
TLX3 T-cell leukemia
homeobox 3
5q35.1 GAGTTAATGAGAGG
AGAGAGGTT
AAAACCCTCCCAA
ATAACT
2157 +220 377 bp
FOXE3 forkhead box E3 1p32 TTAAATATAGTGGGA
TGGGGTT
CTCTAACTCCCG
CCCTAA
260 +354 414 bp
GUCY1A2 guanylate cyclase 1,
soluble, alpha 2
11q21-q22 TTTTTGTTTGGGTCGT
AGTT
TCTTCCTTCGAAA
CATACTACC
288 +326 414 bp
HIST1H4F histone cluster 1, H4f 6p21.3 TAAGGGGTTTTAGTGT
GTAGTAAA
AATAAAACTCAA
CCACCAAAAC
2130 +250 380 bp
OVOL1 ovo-like 1(Drosophila) 11q13 GTAAGGGATTTCGTTT
TTAGGG
CTCCAATTCCTCT
TACACGTAA
240 +277 277 bp
TM6SF1 transmembrane 6
superfamily member 1
15q24-q26 TTGGTAGGAGTATTGT
AAGGACGT
CTCACTCACTCAT
ACTAAACCGC
2214 +152 366 bp
TRIM58 tripartite motif-
containing 58
1q44 GTTTGAGTGGTGGTT
TTTTA
TAACCGACTCCTA
CAAAAAAT
2181 +72 253 bp
ADAM8 Adam metallopeptidase
domain 8
10q26.3 TTTTATTTGTGTAAGG
GAGGATG
ACCCAAAAACCA
CTATACACCT
2142 +287 429 bp
KIF17 kinesin family
member 17
1p36.12 GGGGTTAGTTTTGGT
TTCGT
CATACCCTACCGC
CTACAAA
224 +299 312 bp
GRASP GRP1 (general receptor
for phosphoinositides 1)-
associated scaffold protein
12q13.13 TTTCGGAGTTTATAA
AGGGAG
CGACAAAATAATA
ATCCTCCAAC
2142 +171 313 bp
UTF1 Undifferentiated embryonic
cell transcription factor 1
10q26 GTTAGGATCGATTT
TTTAGGA
CCAACAACAACTC
CGTCT
2232 +174 406 bp
ATP8A2 ATPase, aminophospholipid
transporter, class I, type 8A,
member 2
13q12 TTCGGTTTTGCGTAA
TATTG
CATCTTAAAAACTT
TATCCAAACCT
2238 +135 373 bp
ADCY5 adenylate cyclase 5 3q13.2-q21 GGGGTGTTAAGATG
TTTCGT
AAACTAAAACCGA
AACCCC
2226 +220 446 bp
EPHA4 EPH receptor A4 2q36.1 TTGGTAATGTTTTTA
GTTCGTT
ACCATTCACACTA
AACTCCC
2106 +187 293 bp
BOLL bol, boule-like (Drosophila) 2q33 CGTTAGGTGGTAGGT
TTAGGG
CCAAACCCTCAAA
AACAAAC
225 +258 283 bp
doi:10.1371/journal.pone.0019862.t008
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was determined using the methylation index (MI), which was
calculated as the number of methylated CpG dinucleotides divided
by the total number of CpG dinucleotides sequenced multiplied by
100.
Cell line culture conditions and 5-aza-dc treatment
Four hepatoma cell lines, HepG2, 7402, 97L and 97H, which
were all routinely cultured in our institution, were grown in
DMEM supplemented with 10% FBS at 37uC with humidified 5%
CO2. Cells were seeded in six-well plates 24 hours before
treatment with 10 mM 5-aza-29-deoxycytidine (5-aza-dc; Sigma,
USA) or phosphate-buffered saline as a control. Media and drugs
were replaced every 24 h and the cells were harvested at 72 h
post-treatment.
Real-time quantitative polymerase chain reaction (RT-
PCR) Analysis
Total RNA from the four hepatoma cell lines was extracted
before and after treatment with 5-aza-dc using TRIzol (Invitrogen,
Carlsbad, CA, USA) according to the manufacturer’s protocols.
RNA (1 mg) was reverse-transcribed using the AMV Reverse
Transcription System(Invitrogen, Carlsbad, CA, USA). Primer
sequences are listed in Table 9. RT-PCR was performed with
SYBR Premix Ex TaqTMH (Takara, Japan) on an ABI prism
7500 sequencer. The relative expression levels were analyzed using
the DDCt method, and GAPDH was used as an internal control.
Statistical analysis
Data were evaluated using Student’s t-test for each pair using
SPSS software v16.0. The level of significance for all statistical
analyses was P,0.05.
Supporting Information
Table S1 List of differentially methylated genes in
single hepatocyte derived from HBHC (P,0.001).
(DOC)
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